Organic /Inorganic Hybrids to Guide Bone Regeneration

引导骨再生的有机/无机混合物

基本信息

  • 批准号:
    6686717
  • 负责人:
  • 金额:
    $ 29.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-01 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Reconstruction of orofacial defects represents a major clinical challenge. Existing treatments have limitations and lack predictability, necessitating development of new strategies to heal orofacial tissues. One new approach is to regenerate the tissue(s) of interest by seeding autogenous cells into a biomaterial which supports and may even provide cues for the cells, allowing them to grow, differentiate and secrete new extracellular matrix. Towards this end, we have developed in vitro culture methods in which human bone marrow stromal cells are expanded, and demonstrated that these cells are capable of forming new bone in vivo. The formation of bone from progenitor cells is, however, variable, especially if human cells are used, and is controlled by a number of factors in the cells' microenvironment, including the supporting biomaterial. We therefore seek to establish material parameters that could enhance bone cell function in vitro and in vivo. The global hypothesis is that bone-like mineral/organic hybrids that are co-precipitated onto scaffolds used for BMSC transplantation can be used by the cells to restructure a mineralized extracellular matrix of increased volume and structural integrity, thereby enhancing bone formation by the transplanted cells. Results from our and other laboratories support this hypothesis, which is tested by synthesizing 3 classes of organic/inorganic hybrid materials: organic templates whose surface self-assembles into a biological apatite via the co-precipitation of a mineral/poly amino acid hybrid layer; organic templates whose surface includes cell adhesion molecules co-adsorbed with a mineral phase; and incorporation of growth factors into the self-assembled mineral layer such that the biomineral serves as a controlled delivery vehicle. For each of these biomimetic strategies, we test the hypothesis that co-precipitation of organic and inorganic phases onto scaffold pore surfaces leads to increased osteoblast invasion and osteoconductivity and that the rate and extent of BMSC differentiation toward an osteoblast phenotype in-vitro and in-vivo are regulated by the type and concentration of the organic phase within the mineral. The results of these studies may lead to biomaterials that modulate bone formation by progenitor cells. This approach has implications for cell transplantation, but may also have impact on the differentiation of host cells if used as an inductive approach to tissue engineering.
描述(由申请人提供):口腔面部缺陷的重建是一个主要的临床挑战。现有的治疗方法存在局限性和缺乏可预测性,因此有必要开发新的策略来治疗口腔面部组织。一种新的方法是通过将自体细胞种植到一种生物材料中来再生感兴趣的组织(S),这种生物材料可以支持细胞,甚至可能为细胞提供线索,使它们能够生长、分化和分泌新的细胞外基质。为此,我们开发了人骨髓基质细胞的体外培养方法,并证明了这些细胞能够在体内形成新骨。然而,祖细胞形成骨的过程是多变的,特别是在使用人类细胞的情况下,并且受到细胞微环境中的许多因素的控制,包括支持的生物材料。因此,我们寻求建立能够在体外和体内增强骨细胞功能的材料参数。全球假说是,共沉淀到用于骨髓间充质干细胞移植的支架上的骨样矿物/有机杂交物可以被细胞用来重建体积增加和结构完整的矿化细胞外基质,从而促进移植细胞的骨形成。我们和其他实验室的结果支持这一假说,并通过合成3类有机/无机杂化材料来验证这一假说:有机模板,其表面通过矿物/多氨基酸杂化层的共沉淀而自组装成生物磷灰石;有机模板,其表面包括与矿物相共吸附的细胞黏附分子;以及将生长因子掺入自组装的矿物层,使得生物矿物充当受控输送载体。对于这些仿生策略中的每一种,我们测试了这样的假设,即有机和无机相在支架孔表面的共沉淀导致成骨细胞侵袭性和骨传导性的增加,以及BMSC在体外和体内向成骨细胞表型分化的速度和程度受矿物中有机相的类型和浓度的调节。这些研究的结果可能导致通过祖细胞调节骨形成的生物材料。这种方法对细胞移植有影响,但如果用作组织工程的诱导性方法,也可能对宿主细胞的分化产生影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID H. KOHN其他文献

DAVID H. KOHN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID H. KOHN', 18)}}的其他基金

Engineering anti-fragile tooth/restorative interfaces
工程防脆牙齿/修复界面
  • 批准号:
    9302392
  • 财政年份:
    2016
  • 资助金额:
    $ 29.24万
  • 项目类别:
Structure, Composition, & Histology Core - Core B
结构、组成、
  • 批准号:
    10459375
  • 财政年份:
    2016
  • 资助金额:
    $ 29.24万
  • 项目类别:
Engineering anti-fragile tooth/restorative interfaces
工程防脆牙齿/修复界面
  • 批准号:
    9982297
  • 财政年份:
    2016
  • 资助金额:
    $ 29.24万
  • 项目类别:
Engineering anti-fragile tooth/restorative interfaces
工程防脆牙齿/修复界面
  • 批准号:
    9754109
  • 财政年份:
    2016
  • 资助金额:
    $ 29.24万
  • 项目类别:
Engineering anti-fragile tooth/restorative interfaces
工程防脆牙齿/修复界面
  • 批准号:
    9152370
  • 财政年份:
    2016
  • 资助金额:
    $ 29.24万
  • 项目类别:
Structure, Composition, & Histology Core - Core B
结构、组成、
  • 批准号:
    10676783
  • 财政年份:
    2016
  • 资助金额:
    $ 29.24万
  • 项目类别:
The Use of Erythropoietin to Reprogram Oral and Craniofacial Stem Cells
使用促红细胞生成素重新编程口腔和颅面干细胞
  • 批准号:
    7936104
  • 财政年份:
    2009
  • 资助金额:
    $ 29.24万
  • 项目类别:
The Use of Erythropoietin to Reprogram Oral and Craniofacial Stem Cells
使用促红细胞生成素重新编程口腔和颅面干细胞
  • 批准号:
    7838174
  • 财政年份:
    2009
  • 资助金额:
    $ 29.24万
  • 项目类别:
MicroCT 100
显微CT 100
  • 批准号:
    7793129
  • 财政年份:
    2009
  • 资助金额:
    $ 29.24万
  • 项目类别:
Organic/Inorganic Hybrids to Guide Bone Regeneration
引导骨再生的有机/无机混合物
  • 批准号:
    6897521
  • 财政年份:
    2003
  • 资助金额:
    $ 29.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了